Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Behavioral Medicine
Published in: International Journal of Behavioral Medicine 2/2009

Open Access 01-06-2009

Increased Anxiety and Depression in Danish Cardiac Patients with a Type D personality: Cross-Validation of the Type D Scale (DS14)

Authors: Helle Spindler, Charlotte Kruse, Ann-Dorthe Zwisler, Susanne S. Pedersen

Published in: International Journal of Behavioral Medicine | Issue 2/2009

Login to get access

Abstract

Background

Type D personality is an emerging risk factor in cardiovascular disease. We examined the psychometric properties of the Danish version of the Type D Scale (DS14) and the impact of Type D on anxiety and depression in cardiac patients.

Method

Cardiac patients (n = 707) completed the DS14, the Hospital Anxiety and Depression Scale, and the Eysenck Personality Questionnaire. A subgroup (n = 318) also completed the DS14 at 3 or 12 weeks.

Results

The two-factor structure of the DS14 was confirmed; the subscales negative affectivity and social inhibition were shown to be valid, internally consistent (Cronbach’s α = 0.87/0.91; mean inter-item correlations = 0.49/0.59), and stable over 3 and 12 weeks (r = 0.85/0.78; 0.83/0.79; ps < 0.01). Type D was an independent associate of anxiety (β, 0.49; p < 0.01) and depression (β, 0.47; p < 0.01) in univariable linear regression analysis and remained a significant independent associate of anxiety (β, 0.26; p < 0.01) and depression (β, 0.17; p < 0.01) in adjusted analyses.

Conclusions

The Danish DS14 was shown to be a valid and reliable measure associated with increased symptoms of anxiety and depression independent of socio-demographic and clinical risk factors. The DS14 may be used in research and clinical practice to identify high-risk patients.
Literature
1.
Kop WJ, Appels AP, Mendes de Leon CF, de Swart HB, Bar FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994;56:281–7.PubMed
2.
Pedersen SS, Denollet J. Is type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2006;2:205–13.CrossRef
3.
Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. J Am Coll Cardiol 2005;45:637–51.PubMedCrossRef
4.
Clarke SP, Frasure-Smith N, Lesperance F, Bourassa MG. Psychosocial factors as predictors of functional status at 1 year in patients with left ventricular dysfunction. Res Nurs Health 2000;23:290–300.PubMedCrossRef
5.
Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003;42:1811–7.PubMedCrossRef
6.
Dimsdale JE. A perspective on type A behavior and coronary disease. N Engl J Med 1988;318:110–12.PubMedCrossRef
7.
Denollet J, Van Heck GL. Psychological risk factors in heart disease: what type D personality is (not) about. J Psychosom Res 2001;51:465–8.PubMedCrossRef
8.
Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: A practical review. J Psychosom Res 2000;48:379–91.PubMedCrossRef
9.
Pedersen SS, Denollet J, Spindler H, Ong AT, Serruys PW, Erdman RA, et al. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res 2006;61:783–9.PubMedCrossRef
10.
Pedersen SS, Ong AT, Sonnenschein K, Serruys PW, Erdman RA, van Domburg RT. Type D personality and diabetes predict the onset of depressive symptoms in patients after percutaneous coronary intervention. Am Heart J 2006;151:367.e1–367.e6.CrossRef
11.
Sullivan MD, LaCroix AZ, Spertus JA, Hecht J. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol 2000;86:1135–8, A6, A9.PubMedCrossRef
12.
Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88–90.PubMedCrossRef
13.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–7.PubMedCrossRef
14.
Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000;48:471–8.PubMedCrossRef
15.
Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch Intern Med 2002;162:1860–6.PubMedCrossRef
16.
Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006;27:2763–74.PubMedCrossRef
17.
Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van Domburg RT. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 2006;27:171–7.PubMedCrossRef
18.
Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004;66:714–9.PubMedCrossRef
19.
De Jonge P, Denollet J, Van Melle JP, Kuyper A, Honig A, Schene AH, et al. Associations of type-D personality and depression with somatic health in myocardial infarction patients. J Psychosom Res 2007;63:477–82.PubMedCrossRef
20.
Martens EJ, Kupper N, Pedersen SS, Aquarius AE, Denollet J. Type-D personality is a stable taxonomy in post-MI patient over an 18-months period. J Psychosom Res 2007;63:545–50.PubMedCrossRef
21.
Denollet J. DS14: Standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 2005;67:89–97.PubMedCrossRef
22.
Whitehead DL, Perkins-Porras L, Strike PC, Magid K, Steptoe A. Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality. J Psychosom Res 2007;62(4):419–25.PubMedCrossRef
23.
Denollet J, Vaes J, Brutsaert DL. Inadequate response to treatment in coronary heart disease: Adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000;102:630–5.PubMed
24.
Bunting BP, Adamson G, Mulhall P. A monte carlo examination of MTMM model with planned incomplete data structures. Struct Equ Modeling 2002;9:369–89.CrossRef
25.
Emons WH, Meijer RR, Denollet J. Negative affectivity and social inhibition in cardiovascular disease: Evaluating type-D personality and its assessment using item response theory. J Psychosom Res 2007;63:27–39.PubMedCrossRef
26.
Eysenck SB, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers Individ Differ 1985;6:21–9.CrossRef
27.
Pedersen SS, Denollet J. Validity of the type D personality construct in Danish post-MI patients and healthy controls. J Psychosom Res 2004;57:265–72.PubMedCrossRef
28.
Sanderman R, Arindell WA, Ranchor AV, Eysenck HJ, Eysenck SB. Eysenck personality questionnaire: Een handleiding (Eysenck Personality Questionnaire: Manual). Groningen: Regenboog; 1995.
29.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.PubMedCrossRef
30.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. an updated literature review. J Psychosom Res 2002;52:69–77.PubMedCrossRef
31.
Herrmann C. International experiences with the hospital anxiety and depression scale–a review of validation data and clinical results. J Psychosom Res 1997;42:17–41.PubMedCrossRef
32.
Jöreskog K, Sörbom D. LISREL 8.80. Chicago: Scientific Software International, Inc.; 2006.
33.
Jöreskog K, Sörbom D. PRELIS 2.80. Chicago: Scientific Software International, Inc.; 2006.
34.
Curran PJ, West SG, Finch JF. The robustness of test statistics to nonnormality and specification error in confirmatory factor analysis. Psychol Methods 1996;1:16–29.CrossRef
35.
Satorra A. Asymptotic robust inferences in the analysis of mean and covariance structures. Sociol Method 1992;22:249–514.CrossRef
36.
Hoyle RH, Panter AT. Writing about structural equation models. In: Hoyle RH, editor. Structural equation modeling: Concepts, issues, and applications. Thousand Oaks, CA, US: Sage Publications, Inc.; 1995. p. 158–76.
37.
Bollen KA. Structural equations with latent variables. Oxford, England: Wiley; 1989.
38.
39.
Steiger JH. Structural model evaluation and modification: An interval estimation approach. Multivariate Behav Res 1990;25:173–173.CrossRef
40.
Jöreskog K, Sörbom D. Structural equation modeling with the SIMPLIS command language. Chicago: Scientific Software; 1993.
41.
Jöreskog K, Sörbom D. LISREL V: Analysis of linear structural relationships by the method of maximum likelihood. . Chicago: National Educational Resources; 1981.
42.
Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling 1999;6:1–1.CrossRef
43.
Hu L, Bentler PM. Fit indices in covariance structure modeling: Sensitivity to underparameterized model misspecification. Psychol Methods 1998;3:424–424.CrossRef
44.
Browne MW, Cudeck R. Single sample cross-validation indices for covariance structures. Multivariate Behav Res 1989;24:445–445.CrossRef
45.
Tanaka JS. “How big is big enough?": sample size and goodness of fit in structural equation models with latent variables. Child Dev 1987;58:134–134.CrossRef
46.
Briggs SR, Cheek JM. The role of factor analysis in the development and evaluation of personality scales. J Person. Special Issue: Methodol Dev Person Res 1986;54:106–48.
47.
Frasure-Smith N, Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67:S19–25.PubMedCrossRef
48.
Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004;73:344–52.PubMedCrossRef
49.
Januzzi JL Jr, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000;160:1913–21.PubMedCrossRef
50.
Kubzansky LD, Davidson KW, Rozanski A. The clinical impact of negative psychological states: Expanding the spectrum of risk for coronary artery disease. Psychosom Med 2005;67:S10–4.PubMedCrossRef
51.
Spindler H, Pedersen SS. Posttraumatic stress disorder in the wake of heart disease: Prevalence, risk factors, and future research directions. Psychosom Med 2005;67:715–23.PubMedCrossRef
52.
van Gestel YR, Pedersen SS, van de Sande M, de Jaegere PP, Serruys PW, Erdman RA, et al. Type-D personality and depressive symptoms predict anxiety 12 months post-percutaneous coronary intervention. J Affect Disord 2007;103:197–203.PubMedCrossRef
53.
Spindler H, Pedersen SS, Serruys PW, Erdman RA, van Domburg RT. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era. J Affect Disord 2007;99:173–9.PubMedCrossRef
54.
Doering LV, Dracup K, Caldwell MA, Moser DK, Erickson VS, Fonarow G, et al. Is coping style linked to emotional states in heart failure patients? J Card Fail 2004;10:344–9.PubMedCrossRef
55.
Denollet J, Brutsaert DL. Reducing emotional distress improves prognosis in coronary heart disease: 9-year mortality in a clinical trial of rehabilitation. Circulation 2001;104:2018–23.PubMedCrossRef
56.
Pedersen SS, Denollet J, Ong AT, Serruys PW, Erdman RA, van Domburg RT. Impaired health status in type D patients following PCI in the drug-eluting stent era. Int J Cardiol 2007;114:358–65.PubMedCrossRef
57.
Herrmann C, Brand-Driehorst S, Buss U, Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res 2000;48:455–62.PubMedCrossRef
Metadata
Title
Increased Anxiety and Depression in Danish Cardiac Patients with a Type D personality: Cross-Validation of the Type D Scale (DS14)
Authors
Helle Spindler
Charlotte Kruse
Ann-Dorthe Zwisler
Susanne S. Pedersen
Publication date
01-06-2009
Publisher
Springer US
Published in
International Journal of Behavioral Medicine / Issue 2/2009
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-009-9037-5

Other articles of this Issue 2/2009

International Journal of Behavioral Medicine 2/2009 Go to the issue

OriginalPaper

Self-rated Health and Social Capital Among Aging People Across the Urban–Rural Dimension

OriginalPaper

The Factor Structure of the Illness Attitude Scales in A German Population

OriginalPaper

Health Behavior and Protective Factors Among School Children in Four African Countries

OriginalPaper

The Body Image Avoidance Questionnaire: Assessment of its Construct Validity in a Community Sample of French Adolescents

OriginalPaper

The Life Control Scale: Validation with a Population Cohort of Middle-Aged Australian Women

OriginalPaper

Cross-Language Differential Item Functioning of the Job Content Questionnaire Among European Countries: The JACE Study